Free CME from PeerView


Nephrology CME

Credits: 1.0 CME
Medical Learning Institute, Inc.
A Renewed Look at MRA Therapy: Improving Renal Outcomes and Reducing Risks in Patients With Type 2 Diabetes
Rajiv Agarwal, MD, MS
May 13, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Making the Case for Preventing and Managing Nephropathy in Patients With Fabry Disease
Anjay Rastogi, MD
April 19, 2022
Amit Bar-Or, MD, FRCPC/Daniel S. Reich, MD, PhD
Credits: 1.0 CME
Medical Learning Institute, Inc.
Rationale, Evidence, and Practical Potential for BTK Inhibitors in Patient-Centered MS Care: Where We Stand Now
Amit Bar-Or, MD, FRCPC / Daniel S. Reich, MD, PhD
February 26, 2022
Credits: 0.5 CME
Penn State College of Medicine
Hope Is on the Horizon: The Clinical Potential of Emerging Disease-Modifying Therapies for Managing Complement 3 Glomerulopathy
Carla M. Nester, MD, MSA, FASN
February 24, 2022
Pasi A. Janne, MD, PhD
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Addressing Key Targets in Advanced NSCLC: Evaluating the Latest Evidence and Clinical Opportunities for HER2-, HER3-, and TROP2-Targeted Therapies
Pasi A. Janne, MD, PhD
February 22, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Decisions and Dilemmas in Prostate Cancer Management: Building on Progress to Advance Personalized Care Through Candid Conversations and Expert Clinical Consults
Robert Dreicer, MD, MS, MACP, FASCO
February 19, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Navigating Evolving Standards of Care in Renal Cell Carcinoma: Expert Insights on Selecting and Sequencing Targeted and Immunotherapy Options and a Look at Emerging Strategies
Sumanta Kumar Pal, MD, FASCO
February 18, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Achieving State-of-the-Art Care in Bladder Cancer in an Era of Innovative Therapeutic Solutions
Petros Grivas, MD, PhD
February 18, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Embracing the Era of Individualized Therapy in Advanced Biliary Cancers: Expert Strategies for Applying New and Emerging Targeted Treatment Options Through Precision Medicine
Milind Javle, MD
February 16, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Mapping the Optimal Treatment Route in HCC: Identifying Best Practices in an Expanding Therapeutic Landscape
Richard S. Finn, MD
February 15, 2022
Erika Hamilton, MD
Credits: 1.0 CME
Medical Learning Institute, Inc.
Expanding Treatment Options in ER+/HER2- Breast Cancer: Expert Perspectives on the Rapidly Emerging Role of SERDs, SERMs, and SERCAs, and the Practical Considerations of Leveraging Established and Innovative Therapies
Erika Hamilton, MD
January 19, 2022
Michael Heinrich, MD
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Optimally Sequencing Modern TKIs in GIST: Expert Perspectives From an Interprofessional Sarcoma Team
Michael Heinrich, MD
January 13, 2022
John G. Gribben, MD, DSc, FRCP, FRCPath, FMedSci
Credits: 2.0 CME
Penn State College of Medicine
Achieving Innovation in CLL Care: Evidence-Informed Choices With Targeted Options and Next Steps in Disease Management
John G. Gribben, MD, DSc, FRCP, FRCPath, FMedSci
December 30, 2021
Credits: 0.25 CME
Penn State College of Medicine
Disparities in the Management of Inflammatory Bowel Disease: Expert Perspectives on the Role of Race and Socioeconomic Factors on Care Delivery and Effectiveness
Sunanda Kane, MD
December 17, 2021
Credits: 1.5 CME / MOC / NCPD
Medical Learning Institute, Inc.
Expert Perspectives on Improving Early Recognition of Eosinophilic Esophagitis and Examining the Potential Clinical Utility of Emerging Targeted Therapy
Amal H. Assa'ad, MD
December 14, 2021
Credits: 1.5 CME
Medical Learning Institute, Inc.
A Better Blend for Follicular Lymphoma: How Targeted, Epigenetic, and Immune Therapies Are Changing Patient Care
Nathan H. Fowler, MD
December 10, 2021
John C. Byrd, MD
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Customizing Care in CLL With BTK Inhibitors: Evidence and Applications for Therapy Selection, Sequencing, and Safety Management
John C. Byrd, MD
December 10, 2021
Credits: 2.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
The Evolution of Sickle Cell Disease: Current Advances and Future Possibilities
Biree Andemariam, MD
December 10, 2021
Credits: 1.5 CME / MOC / NCPD
Medical Learning Institute, Inc.
Personalizing Treatment Decisions in HER2-Altered Breast Cancer: Strategies for Improving Equity and Patient Outcomes Through Individualized Targeted Therapy Selection, Team-Based Care, and Shared Decision-Making
Joyce O’Shaughnessy, MD
December 10, 2021
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
A Is for Antibody in Multiple Myeloma: Practical Insights and Patient Voices Along the Therapeutic Journey
Suzanne Lentzsch, MD, PhD
December 10, 2021
Caron Jacobson, MD
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Unlocking the Benefits of CAR-T Therapy in Hematologic Malignancies: Latest Evidence and Practical Considerations for Delivering State-of-the-Art Care
Caron Jacobson, MD
December 10, 2021
Credits: 2 CME / MOC
Medical Learning Institute, Inc.
Seizing Opportunity in AML: How to Realize the Potential of Novel Therapeutics in Diverse Patient Populations
Naval Daver, MD
December 10, 2021
Credits: 1.5 CPE
Medical Learning Institute, Inc.
Advancing the Standard of Care for Patients with Hyperkalemia: Insights and Evidence for Clinical Pharmacy Practice
George L. Bakris, MD
December 07, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Personalizing and Advancing Modern Treatment Approaches to Prostate Cancer
Robert Dreicer, MD, MS, MACP, FASCO / Pedro C. Barata, MD, MSc
December 01, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Breaking Down the Evidence in Bladder Cancer: Expert Perspectives and Practical Strategies on Immune, Targeted, and Antibody-Based Therapies
Petros Grivas, MD, PhD
December 01, 2021
Credits: 0.5 CME
University of Cincinnati
Addressing Unmet Needs in the Treatment of Primary Sjögren’s Syndrome: Expert Insight on the Therapeutic Potential for CD40 Pathway Blockade
Steven E. Carsons, MD
November 23, 2021
Credits: 0.5 CME / MOC
Medical Learning Institute, Inc.
Visualizing Progress With BTK Inhibitors: An Animated Journey Through the Mechanisms of Covalent and Noncovalent Options
Nirav Shah, MD, MS
November 19, 2021
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Translating Science, Transforming Practice, and Making Headway Toward Better Outcomes in SCLC: Immunotherapy Has Changed the Game, but Where Do We Go Next?
Jonathan W. Goldman, MD
November 18, 2021
David Malebranche, MD, MPH / Peter Shalit, MD, PhD
Credits: 1.0 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Parallel Perspectives: A Unique Look at HIV Treatment Decisions From the Provider and the Patient
David Malebranche, MD, MPH / Peter Shalit, MD, PhD
November 17, 2021
Credits: 1 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Improving the Detection and Management of Cardiac Immune-Related Adverse Events in Patients With Cancer Is a Must: Are You Prepared?
Javid Moslehi, MD
November 15, 2021

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView